Multi-target-Directed Ligands To Combat Neurodegenerative Diseases

Cited by (1,000)

Items 201–300 of 1,000

1. Design, synthesis and evaluation of 4′-OH-flurbiprofen-chalcone hybrids as potential multifunctional agents for Alzheimer’s disease treatment
   Zhongcheng Cao, Jie Yang, Rui Xu, Qin Song, Xiaoyu Zhang, Hongyan Liu, Xiaoming Qiang, Yan Li, Zhenghuai Tan, Yong Deng · 2018 · Bioorganic & Medicinal Chemistry
2. Synthesis and evaluation of tetrahydroisoquinoline-benzimidazole hybrids as multifunctional agents for the treatment of Alzheimer's disease
   Yuying Fang, Huihao Zhou, Qiong Gu, Jun Xu · 2019 · European Journal of Medicinal Chemistry
3. Design, biological evaluation and X-ray crystallography of nanomolar multifunctional ligands targeting simultaneously acetylcholinesterase and glycogen synthase kinase-3
   Killian Oukoloff, Nicolas Coquelle, Manuela Bartolini, Marina Naldi, Rémy Le Guével, Stéphane Bach, Béatrice Josselin, Sandrine Ruchaud, Marco Catto, Leonardo Pisani et al. · 2019 · European Journal of Medicinal Chemistry
4. Prospects of multitarget drug designing strategies by linking molecular docking and molecular dynamics to explore the protein–ligand recognition process
   Sivakumar Krishnankutty Chandrika, Jin Haixiao, C. Benjamin Naman, T. P. Sajeevan · 2020 · Drug Development Research
5. Design and synthesis of 3-(4-pyridyl)-5-(4-sulfamido-phenyl)-1,2,4-oxadiazole derivatives as novel GSK-3β inhibitors and evaluation of their potential as multifunctional anti-Alzheimer agents
   Min Wang, Tongtong Liu, Shiming Chen, Mingfei Wu, Jianfei Han, Zeng Li · 2020 · European Journal of Medicinal Chemistry
6. Novel Benzoxazine and Benzothiazine Derivatives as Multifunctional Antihyperlipidemic Agents
   Alexios N. Matralis, Maria G. Katselou, Anastasios Nikitakis, Angeliki P. Kourounakis · 2011 · Journal of Medicinal Chemistry
7. Searching for multi-target antipsychotics: Discovery of orally active heterocyclic N-phenylpiperazine ligands of D2-like and 5-HT1A receptors
   Gilda Angela Neves, Ricardo Menegatti, Camila Boque Antonio, Luiza Raquel Grazziotin, Renan O. Vieira, Stela Maris Kuze Rates, François Noël, Eliezer J. Barreiro, Carlos Alberto Manssour Fraga · 2010 · Bioorganic & Medicinal Chemistry
8. Design, Synthesis, and Biological Evaluation of Coumarin Derivatives Tethered to an Edrophonium‐like Fragment as Highly Potent and Selective Dual Binding Site Acetylcholinesterase Inhibitors
   Leonardo Pisani, Marco Catto, Ilenia Giangreco, Francesco Leonetti, Orazio Nicolotti, Angela Stefanachi, Saverio Cellamare, Angelo Carotti · 2010 · ChemMedChem
9. Design, synthesis and pharmacological evaluation of N -benzyl-piperidinyl-aryl-acylhydrazone derivatives as donepezil hybrids: Discovery of novel multi-target anti-alzheimer prototype drug candidates
   Flávia Pereira Dias Viegas, Matheus de Freitas Silva, Miguel Divino da Rocha, Maísa R. Castelli, Mariana M. Riquiel, Rafael Pereira Machado, Sarah Macedo Vaz, Laís Medeiros Simões de Lima, Karla Cristine Mancini, Patrícia C. M. de Oliveira et al. · 2018 · European Journal of Medicinal Chemistry
10. O-Hydroxyl- or o-amino benzylamine-tacrine hybrids: Multifunctional biometals chelators, antioxidants, and inhibitors of cholinesterase activity and amyloid-β aggregation
    Fei Mao, Ling Huang, Zonghua Luo, Anqiu Liu, Chuan‐Jun Lu, Zhi Xie, Xingshu Li · 2012 · Bioorganic & Medicinal Chemistry
11. Synthesis and evaluation of heterobivalent tacrine derivatives as potential multi-functional anti-Alzheimer agents
    Wen Luo, Yan‐Ping Li, Yan He, Shi‐Liang Huang, Ding Li, Lian‐Quan Gu, Zhi‐Shu Huang · 2011 · European Journal of Medicinal Chemistry
12. Modulating 5-Ht 4 and 5-Ht 6 Receptors in Alzheimer’S Disease Treatment
    Julien Lalut, Delphine Karila, Patrick Dallemagne, Christophe Rochais · 2017 · Future Medicinal Chemistry
13. Newly Developed Drugs for Alzheimer’s Disease in Relation to Energy Metabolism, Cholinergic and Monoaminergic Neurotransmission
    Korábečný, Jan, Nepovimová, Eugenie, Cikánková, Tereza, Špilovská, Katarína, Vašková, Lucie, Mezeiová, Eva, Kuča, Kamil, Hroudová, Jana · 2018 · Neuroscience
14. Design, synthesis and biological evaluation of new benzoxazolone/benzothiazolone derivatives as multi-target agents against Alzheimer’s disease
    Merve Erdoğan, Burcu Kılıç, Rahşan Ilıkçı Sağkan, Fatma Aksakal, Tuğba Erçeti̇n, Hayrettin Ozan Gülcan, Deniz S. Doğruer · 2020 · European Journal of Medicinal Chemistry
15. Computational drug development for membrane protein targets
    Haijian Li, Xiaolin Sun, Wenqiang Cui, Marc Xu, Junlin Dong, Babatunde Ekundayo, Dongchun Ni, Zhili Rao, Liwei Guo, Henning Stahlberg et al. · 2024 · Nature Biotechnology
16. Novel tacrine–ebselen hybrids with improved cholinesterase inhibitory, hydrogen peroxide and peroxynitrite scavenging activity
    Fei Mao, Jianwen Chen, Qi Zhou, Zonghua Luo, Ling Huang, Xingshu Li · 2013 · Bioorganic & Medicinal Chemistry Letters
17. Celastrol from ‘Thunder God Vine’ Protects SH-SY5Y Cells Through the Preservation of Mitochondrial Function and Inhibition of p38 MAPK in a Rotenone Model of Parkinson’s Disease
    Bong-Suk Choi, Hyool Kim, Hyo‐Jeong Lee, Kumar Sapkota, Se Eun Park, Seung Kim, Sung-Jun Kim · 2013 · Neurochemical Research
18. Potential role of the combination of galantamine and memantine to improve cognition in schizophrenia
    Maju Mathew Koola, Robert W. Buchanan, Anilkumar Pillai, Katherine Jean Aitchison, Daniel R. Weinberger, Scott T. Aaronson, Faith Dickerson · 2014 · Schizophrenia Research
19. Development of (S)-N6-(2-(4-(Isoquinolin-1-yl)piperazin-1-yl)ethyl)-N6-propyl-4,5,6,7-tetrahydrobenzo[d]-thiazole-2,6-diamine and Its Analogue as a D3 Receptor Preferring Agonist: Potent in Vivo Activity in Parkinson’s Disease Animal Models
    Balaram Ghosh, Tamara Antonio, Juan Zhen, Prashant S. Kharkar, Maarten E. A. Reith, Aloke K. Dutta · 2009 · Journal of Medicinal Chemistry
20. Synthesis and evaluation of frentizole-based indolyl thiourea analogues as MAO/ABAD inhibitors for Alzheimer’s disease treatment
    Lukáš Hroch, Patrick N. Guest, Ondřej Benek, Ondřej Soukup, Jana Janočková, Rafael Doležal, Kamil Kuča, Laura Aitken, Terry Smith, Frank J. Gunn‐Moore et al. · 2016 · Bioorganic & Medicinal Chemistry
21. Discovery and In Vivo Proof of Concept of a Highly Potent Dual Inhibitor of Soluble Epoxide Hydrolase and Acetylcholinesterase for the Treatment of Alzheimer’s Disease
    Sandra Codony, Caterina Pont, Christian Griñán‐Ferré, Ania Di Pede-Mattatelli, Carla Calvó‐Tusell, Ferran Feixas, Sílvia Osuna, Júlia Jarné‐Ferrer, Marina Naldi, Manuela Bartolini et al. · 2022 · Journal of Medicinal Chemistry
22. From Anti-Parkinson's Drug Rasagiline to Novel Multitarget Iron Chelators with Acetylcholinesterase and Monoamine Oxidase Inhibitory and Neuroprotective Properties for Alzheimer's Disease
    Hailin Zheng, Tamar Amit, Orit Bar‐Am, Mati Fridkin, Moussa B. H. Youdim, Silvia A. Mandel · 2012 · Journal of Alzheimer s Disease
23. Ruthenium(II) polypyridyl complex as inhibitor of acetylcholinesterase and Aβ aggregation
    Nilima A. Vyas, Satish Shantaram Bhat, Avinash S. Kumbhar, Uddhavesh Sonavane, Vinod Jani, Rajendra Joshi, Suman Ramteke, Prasad Padmakar Kulkarni, Bimba N. Joshi · 2014 · European Journal of Medicinal Chemistry
24. Design, Synthesis, Biological Properties, and Molecular Modeling Investigations of Novel Tacrine Derivatives with a Combination of Acetylcholinesterase Inhibition and Cannabinoid CB1Receptor Antagonism
    Jos H.M. Lange, Hein K. A. C. Coolen, Martina A.W. van der Neut, Alice J. M. Borst, Bob Stork, Peter C. Verveer, Chris Gerrit Kruse · 2010 · Journal of Medicinal Chemistry
25. Characterization of Tunable Piperidine and Piperazine Carbamates as Inhibitors of Endocannabinoid Hydrolases
    Jonathan Z. Long, Xin Jin, Alexander Adibekian, Weiwei Li, Benjamin F. Cravatt · 2010 · Journal of Medicinal Chemistry
26. Latest advances in dual inhibitors of acetylcholinesterase and monoamine oxidase B against Alzheimer’s disease
    Zou, Dajiang, Liu, Renzheng, Lv, Yangjing, Guo, Jianan, Zhang, Changjun, Xie, Yuanyuan · 2023 · Journal of Enzyme Inhibition and Medicinal Chemistry
27. “Clicked” Bivalent Ligands Containing Curcumin and Cholesterol As Multifunctional Aβ Oligomerization Inhibitors: Design, Synthesis, and Biological Characterization
    James A. Lenhart, Ling Zhi XIAO, Ronak Gandhi, Tai Liang Guo, Phillip M. Gerk, Darlene H. Brunzell, Shijun Zhang · 2010 · Journal of Medicinal Chemistry
28. Design, synthesis, and biological evaluation of 2-arylethenylquinoline derivatives as multifunctional agents for the treatment of Alzheimer's disease
    Xiaoqin Wang, Chunli Xia, Shuo-Bin Chen, Jia‐Heng Tan, Tian‐Miao Ou, Shi‐Liang Huang, Ding Li, Lian‐Quan Gu, Zhi‐Shu Huang · 2014 · European Journal of Medicinal Chemistry
29. Synthesis and evaluation of selegiline derivatives as monoamine oxidase inhibitor, antioxidant and metal chelator against Alzheimer’s disease
    Shishun Xie, Jie Chen, Xiruo Li, Tao Su, Yali Wang, Zhiren Wang, Ling Huang, Xingshu Li · 2015 · Bioorganic & Medicinal Chemistry
30. Synthesis and biological evaluation of new tetramethylpyrazine‐based chalcone derivatives as potential anti‐Alzheimer agents
    Meng Wang, Hua‐Li Qin, Jing Leng, Ameeduzzafar Zafar, Muhammad Wahab Amjad, Maria Abdul Ghafoor Raja, Muhammad Ajaz Hussain, Syed Nasir Abbas Bukhari · 2018 · Chemical Biology & Drug Design
31. Tacrine hybrids as multi-target-directed ligands in Alzheimer’s disease: influence of chemical structures on biological activities
    Małgorzata K. Girek, Paweł Szymański · 2018 · Chemical Papers
32. Donepezil + chromone + melatonin hybrids as promising agents for Alzheimer’s disease therapy
    Irène Pachón-Angona, Bernard Refouvelet, Rudolf Andrýs, Hélène Martin, Vincent Luzet, Isabel Iriepa, Ignacio Moraleda, Daniel Diez‐Iriepa, María Jesús Oset‐Gasque, Jose Luis Marco et al. · 2019 · Journal of Enzyme Inhibition and Medicinal Chemistry
33. The Human Kinome Targeted by FDA Approved Multi-Target Drugs and Combination Products: A Comparative Study from the Drug-Target Interaction Network Perspective
    Yinghong Li, Panpan Wang, Xiao Xu Li, Chun Yan Yu, Hong Jun Yang, Jin Zhou, Weiwei Xue, Jun Tan, Feng Zhu · 2016 · PLoS ONE
34. Design, synthesis, and pharmacological evaluation of 2-amino-5-nitrothiazole derived semicarbazones as dual inhibitors of monoamine oxidase and cholinesterase: effect of the size of aryl binding site
    Rati Kailash Prasad Tripathi, Vishnu Mini Sasi, Sukesh Kumar Gupta, Sairam Krishnamurthy, Senthil Raja Ayyannan · 2017 · Journal of Enzyme Inhibition and Medicinal Chemistry
35. Changing Paradigm from one Target one Ligand Towards Multi-target Directed Ligand Design for Key Drug Targets of Alzheimer Disease: An Important Role of In Silico Methods in Multi-target Directed Ligands Design
    Akhil Kumar, Ashish Kumar Tiwari, Ashok Kumar Sharma · 2018 · Current Neuropharmacology
36. Docking Screens for Dual Inhibitors of Disparate Drug Targets for Parkinson’s Disease
    Mariama Jaiteh, Alexey A. Zeifman, Marcus Saarinen, Per Svenningsson, Jose Manuel Brea, Marı́a Isabel Loza, Jens Carlsson · 2018 · Journal of Medicinal Chemistry
37. Neuroprotective activities of natural products from marine macroalgae during 1999–2015
    Alghazwi, Mousa, Kan, Yen Qi, Zhang, Wei, Gai, Wei Ping, Garson, Mary J., Smid, Scott · 2016 · Journal of Applied Phycology
38. Synthesis, biological assessment and molecular modeling of new dihydroquinoline-3-carboxamides and dihydroquinoline-3-carbohydrazide derivatives as cholinesterase inhibitors, and Ca channel antagonists
    Isabelle Tomassoli, Lhassane Ismaïli, Marc Pudlo, Cristóbal de los Rı́os, Elena Soriano, Inés Colmena, Luis Gandı́a, Luís Rivas, Abdelouahid Samadi, Jose Luis Marco et al. · 2010 · European Journal of Medicinal Chemistry
39. Hydroxycoumarins as selective MAO-B inhibitors
    Silvia Serra, Giulio Ferino, María João Matos, Saleta Vázquez-Rodríguez, Giovanna Delogu, Dolores Viña, Enzo Cadoni, Lourdes Santana, Eugenio Uriarte · 2011 · Bioorganic & Medicinal Chemistry Letters
40. Synthesis and molecular modelling studies of 8-arylpyrido[3′,2′:4,5]thieno[3,2-d]pyrimidin-4-amines as multitarget Ser/Thr kinases inhibitors
    Yvonnick Loidreau, Emmanuel Deau, Pascal Marchand, Marie‐Renée Nourrisson, Cédric Logé, Gaël Coadou, Nadège Loaëc, Laurent Meijer, Thierry Besson · 2014 · European Journal of Medicinal Chemistry
41. Novel drug targets based on metallobiology of Alzheimer's disease
    Sanghamitra Bandyopadhyay, Xudong Huang, Debomoy K. Lahiri, Jack T. Rogers · 2010 · Expert Opinion on Therapeutic Targets
42. Structure−Activity Relationships of Acetylcholinesterase Noncovalent Inhibitors Based on a Polyamine Backbone. 4. Further Investigation on the Inner Spacer
    Vincenzo Tumiatti, Andrea Milelli, Anna Minarini, Michela Rosini, María Laura Bolognesi, Marialuisa Micco, Vincenza Andrisano, Manuela Bartolini, Francesca Mancini, Maurizio Recanatini et al. · 2008 · Journal of Medicinal Chemistry
43. Commonalities in Biological Pathways, Genetics, and Cellular Mechanism between Alzheimer Disease and Other Neurodegenerative Diseases: An In Silico-Updated Overview
    Khurshid Ahmad, Mohammad Hassan Baig, Gohar Mushtaq, Mohammad Amjad Kamal, Nigel H. Greig, Inho Choi · 2017 · Current Alzheimer Research
44. Design, synthesis and biochemical evaluation of novel multi-target inhibitors as potential anti-Parkinson agents
    Simone Carradori, Francesco Ortuso, Anél Petzer, Donatella Bagetta, Celeste De Monte, Daniela Secci, Daniela De Vita, Paolo Guglielmi, Gökhan Zengin, Abdurrahman Aktümsek et al. · 2017 · European Journal of Medicinal Chemistry
45. New multifunctional melatonin-derived benzylpyridinium bromides with potent cholinergic, antioxidant, and neuroprotective properties as innovative drugs for Alzheimer's disease
    Xiaoting Luo, Chunming Wang, Yun Liu, Zhenguang Huang · 2015 · European Journal of Medicinal Chemistry
46. Polyamines in Drug Discovery: From the Universal Template Approach to the Multitarget-Directed Ligand Design Strategy
    Carlo Melchiorre, María Laura Bolognesi, Anna Minarini, Michela Rosini, Vincenzo Tumiatti · 2010 · Journal of Medicinal Chemistry
47. Synthesis, biological evaluation and molecular dynamic simulations of novel Benzofuran-tetrazole derivatives as potential agents against Alzheimer’s disease
    Pragati Kushwaha, Soobiya Fatima, Akanksha Upadhyay, Sampa Gupta, Sudha Bhagwati, Tanvi Baghel, Mohammad Imran Siddiqi, Aamir Nazir, Koneni V. Sashidhara · 2018 · Bioorganic & Medicinal Chemistry Letters
48. Synthesis, In Vitro Biological Evaluation and In Silico Molecular Docking Studies of Indole Based Thiadiazole Derivatives as Dual Inhibitor of Acetylcholinesterase and Butyrylchloinesterase
    Shoaib Khan, Shahid Iqbal, Muhammad Taha, Fazal Rahim, Mazloom Shah, Hayat Ullah, Ali Bahadur, Hamad Alrbyawi, Ayed A. Dera, Mohammed Issa Alahmdi et al. · 2022 · Molecules
49. New insights into butyrylcholinesterase: Pharmaceutical applications, selective inhibitors and multitarget-directed ligands
    Tian‐Yu Sun, Tengfei Zhen, Chrisanta Hamis Harakandi, Lei Wang, Huanchao Guo, Yao Chen, Haopeng Sun · 2024 · European Journal of Medicinal Chemistry
50. Design, Synthesis and Evaluation of Novel 2‐(Aminoalkyl)‐isoindoline‐1,3‐dione Derivatives as Dual‐Binding Site Acetylcholinesterase Inhibitors
    Michalina Ignasik, Marek Bajda, Natalia Szałaj, Michaela Prinz, Ulrike Holzgrabe, Barbara Malawska · 2012 · Archiv der Pharmazie
51. New Tacrine Hybrids with Natural‐Based Cysteine Derivatives as Multitargeted Drugs for Potential Treatment of Alzheimer's Disease
    Rangappa Sangappa Keri, Catarina Quintanova, Sı́lvia Chaves, Diana Filipa Silva, Sandra M. Cardoso, Maria Amélia Santos · 2015 · Chemical Biology & Drug Design
52. Synthesis and evaluation of donepezil–ferulic acid hybrids as multi-target-directed ligands against Alzheimer's disease
    Wei Xu, Xiaobing Wang, Zhi-Min Wang, Jia‐Jia Wu, Fan Li, Jin Wang, Ling‐Yi Kong · 2016 · MedChemComm
53. Design, synthesis and evaluation of coumarin-pargyline hybrids as novel dual inhibitors of monoamine oxidases and amyloid- β aggregation for the treatment of Alzheimer's disease
    Huali Yang, Pei Cai, Qiaohong Liu, Xuelian Yang, Fan Li, Jin Qiang Wang, Jia‐Jia Wu, Xiaobing Wang, Ling‐Yi Kong · 2017 · European Journal of Medicinal Chemistry
54. Rational Design and Multibiological Profiling of Novel Donepezil–Trolox Hybrids against Alzheimer’s Disease, with Cholinergic, Antioxidant, Neuroprotective, and Cognition Enhancing Properties
    Pei Cai, Siqiang Fang, Xuelian Yang, Jia‐Jia Wu, Qiaohong Liu, Hao Hong, Xiaobing Wang, Lingyi Kong · 2017 · ACS Chemical Neuroscience
55. Docking, molecular dynamics, binding energy-MM-PBSA studies of naphthofuran derivatives to identify potential dual inhibitors against BACE-1 and GSK-3β
    Akhil Kumar, Gaurava Srivastava, Arvind Negi, Ashok Kumar Sharma · 2018 · Journal of Biomolecular Structure and Dynamics
56. Mulberry Diels-Alder-type adducts from Morus alba as multi-targeted agents for Alzheimer's disease
    Chunli Xia, Gui‐Hua Tang, Yan‐Qiong Guo, You‐Kai Xu, Zhi‐Shu Huang, Sheng Yin · 2018 · Phytochemistry
57. Progress in Target Drug Molecules for Alzheimer's Disease
    Jiayang Xie, Ruirui Liang, Yan‐Jiang Wang, Junyi Huang, Xin Cao, Bing Niu · 2019 · Current Topics in Medicinal Chemistry
58. New Multifunctional Agents Based on Conjugates of 4-Amino-2,3-polymethylenequinoline and Butylated Hydroxytoluene for Alzheimer’s Disease Treatment
    Галина Ф. Махаева, Надежда Владимировна Ковалева, Елена Владимировна Рудакова, Natalia P. Boltneva, Sofya V. Lushchekina, Irina I. Faingold, Darya A. Poletaeva, Yu. V. Soldatova, Raisa A. Kotelnikova, Igor V. Serkov et al. · 2020 · Molecules
59. Enriching Proteolysis Targeting Chimeras with a Second Modality: When Two Are Better Than One
    Alessandra Salerno, Francesca Seghetti, Jessica Caciolla, Elisa Uliassi, Eleonora Testi, Melissa Guardigni, Marinella Roberti, Andrea Milelli, María Laura Bolognesi · 2022 · Journal of Medicinal Chemistry
60. Dual-target inhibitors based on acetylcholinesterase: Novel agents for Alzheimer's disease
    Xingyi Zhao, Qiaoguan Hu, Xiaoqian Wang, Chunting Li, Xiao Chen, Dong Hui Zhao, Yue Qiu, Haoyu Xu, Jiaqi Wang, Le Ren et al. · 2024 · European Journal of Medicinal Chemistry
61. Evaluation of various inverse docking schemes in multiple targets identification
    Huifang Liu, Qing Shen, Jian Zhang, Wei Fu · 2010 · Journal of Molecular Graphics and Modelling
62. Toxicological and pharmacological evaluation, antioxidant, ADMET and molecular modeling of selected racemic chromenotacrines {11-amino-12-aryl-8,9,10,12-tetrahydro-7H-chromeno[2,3-b]quinolin-3-ols} for the potential prevention and treatment of Alzheimer's disease
    María Jesús Oset‐Gasque, María Pilar González, Javier Pérez‐Peña, Nuria García-Font, Alejandro Romero, Javier del Pino, Eva Ramos, Dimitra Hadjipavlou‐Litina, Elena Soriano, Mourad Chioua et al. · 2014 · European Journal of Medicinal Chemistry
63. Synergistic effect of acetylcholinesterase inhibition (donepezil) and 5-HT4 receptor activation (RS67333) on object recognition in mice
    Thomas Fréret, Valentine Bouët, Anne Quiedeville, Gérald Née, Patrick Dallemagne, Christophe Rochais, Michel Boulouard · 2012 · Behavioural Brain Research
64. Multipotent drugs with cholinergic and neuroprotective properties for the treatment of Alzheimer and neuronal vascular diseases. I. Synthesis, biological assessment, and molecular modeling of simple and readily available 2-aminopyridine-, and 2-chloropyridine-3,5-dicarbonitriles
    Abdelouahid Samadi, Jose Luis Marco, Elena Soriano, Mónica Álvarez-Pérez, Mourad Chioua, Alejandro Romero, Laura González‐Lafuente, Luis Gandı́a, Jose María Roda, Manuela G. López et al. · 2010 · Bioorganic & Medicinal Chemistry
65. Tetrahydropyrroloquinolinone Type Dual Inhibitors of Aromatase/Aldosterone Synthase as a Novel Strategy for Breast Cancer Patients with Elevated Cardiovascular Risks
    Lina Yin, Qingzhong Hu, Rolf W. Hartmann · 2013 · Journal of Medicinal Chemistry
66. Novel Multitarget-Directed Ligands Aiming at Symptoms and Causes of Alzheimer’s Disease
    Anna Więckowska, Tomasz Wichur, Justyna Godyń, Adam Bucki, Monika Marcinkowska, Agata Siwek, Krzysztof Więckowski, Paula Zaręba, Damijan Knez, Monika Głuch‐Lutwin et al. · 2018 · ACS Chemical Neuroscience
67. Rational discovery of dual-indication multi-target PDE/Kinase inhibitor for precision anti-cancer therapy using structural systems pharmacology
    Hansaim Lim, Di He, Yue Qiu, Patrycja Krawczuk, Xiaoru Sun, Lei Xie · 2019 · PLoS Computational Biology
68. Recent Advances in the Rational Drug Design Based on Multi-target Ligands
    Ting Yang, Xin Sui, Bing Yu, Youqing Shen, Hailin Cong · 2020 · Current Medicinal Chemistry
69. A novel multi-target ligand (JM-20) protects mitochondrial integrity, inhibits brain excitatory amino acid release and reduces cerebral ischemia injury in vitro and in vivo
    Yanier Núñez-Figueredo, Jeney Ramírez-Sánchez, Gisele Hansel, Elisa Nicoloso Simões Pires, Nelsón Merino, Odalys Valdés, René Delgado, Alicia Lagarto Parra, Estael Ochoa, Yamila Verdecia-Reyes et al. · 2014 · Neuropharmacology
70. Novel fentanyl-based dual μ/δ-opioid agonists for the treatment of acute and chronic pain
    Alexander T. Podolsky, Alexander J. Sandweiss, Jackie Hu, Edward J. Bilsky, Jim P. Cain, Vlad K. Kumirov, Yeon Sun Lee, Victor J. Hruby, Ruben Vardanyan, Todd W. Vanderah · 2013 · Life Sciences
71. Replacement of Imidazolyl by Pyridyl in Biphenylmethylenes Results in Selective CYP17 and Dual CYP17/CYP11B1 Inhibitors for the Treatment of Prostate Cancer
    Qingzhong Hu, Carsten Jagusch, Ulrike E. Hille, Jörg Haupenthal, Rolf W. Hartmann · 2010 · Journal of Medicinal Chemistry
72. Colchicine prodrugs and codrugs: Chemistry and bioactivities
    Abdullah A. Ghawanmeh, Kwok Feng Chong, Shaheen M. Sarkar, Muntaz Abu Bakar, Rizafizah Othaman, Rozida Mohd Khalid · 2017 · European Journal of Medicinal Chemistry
73. Discovery of coumarin Mannich base derivatives as multifunctional agents against monoamine oxidase B and neuroinflammation for the treatment of Parkinson's disease
    Deng Tao, Yue Wang, Xiu-Qi Bao, Beibei Yang, Fan Gao, Lin Wang, Dan Zhang, Li Li · 2019 · European Journal of Medicinal Chemistry
74. Chromone and donepezil hybrids as new multipotent cholinesterase and monoamine oxidase inhibitors for the potential treatment of Alzheimer's disease
    Xiaobing Wang, Fucheng Yin, Ming Y. Huang, Neng Jiang, Jinshuai Lan, Ling‐Yi Kong · 2020 · RSC Medicinal Chemistry
75. Marine Natural Products, Multitarget Therapy and Repurposed Agents in Alzheimer’s Disease
    Márcia Martins, Renata Silva, Madalena M. M. Pinto, Emı́lia Sousa · 2020 · Pharmaceuticals
76. Synthesis of Benzimidazole–Based Analogs as Anti Alzheimer’s Disease Compounds and Their Molecular Docking Studies
    Bushra Adalat, Fazal Rahim, Muhammad Taha, Foziah Alshamrani, El Hassane Anouar, Nizam Uddin, Syed Adnan Alı Shah, Zarshad Ali, Zainul Amiruddin Zakaria · 2020 · Molecules
77. Multi-Target-Directed Ligands as an Effective Strategy for the Treatment of Alzheimer’s Disease
    Rakesh Kumar, Vinod Kumar, Bhupinder Kumar, Amandeep Thakur, Ashish Ranjan Dwivedi · 2021 · Current Medicinal Chemistry
78. Exploring indole-based-thiadiazole derivatives as potent acetylcholinesterase and butyrylcholinesterase enzyme inhibitors
    Muhammad Taha, Fazal Rahim, Nizam Uddin, Ihsan Ullah Khan, Naveed Iqbal, El Hassane Anouar, Mohammed Salahuddin, Rai Khalid Farooq, Mohammed Abdul Salam Gollapalli, Khalid Mohammed Khan et al. · 2021 · International Journal of Biological Macromolecules
79. Effects of melatonin and its analogues on neural stem cells
    Jiaqi Chu, Yalin Tu, Jingkao Chen, Dunxian X Tan, Xingguo Liu, Rongbiao Pi · 2015 · Molecular and Cellular Endocrinology
80. Multi-target therapeutics for neuropsychiatric and neurodegenerative disorders
    Priya Bawa, Priyamvada Pradeep, Pradeep Kumar, Yahya Essop Choonara, Girish Modi, Viness Pillay · 2016 · Drug Discovery Today
81. Design, Synthesis and Multitarget Biological Profiling of Second-Generation Anti-Alzheimer Rhein–Huprine Hybrids
    Francisco Javier Pérez-Areales, Nibal Betari, Antonio Viayna, Caterina Pont, Alba Espargaró, Manuela Bartolini, Angela De Simone, José Fernando Rinaldi de Alvarenga, Belén Pérez, Raimon Sabaté et al. · 2017 · Future Medicinal Chemistry
82. Novel 3-phenylcoumarin–lipoic acid conjugates as multi-functional agents for potential treatment of Alzheimer's disease
    Leili Jalili‐Baleh, Hamid Nadri, Hamid Forootanfar, Alireza Samzadeh‐Kermani, Tuba Tüylü Küçükkılınç, Beyza Ayazgök, Mahban Rahimifard, Maryam Baeeri, Mohsen Doostmohammadi, Loghman Firoozpour et al. · 2018 · Bioorganic Chemistry
83. Neuroprotective Properties of Resveratrol and Its Derivatives—Influence on Potential Mechanisms Leading to the Development of Alzheimer’s Disease
    Michał Wiciński, Anna Domanowska, Eryk Wódkiewicz, Bartosz Malinowski · 2020 · International Journal of Molecular Sciences
84. Amiridine-piperazine hybrids as cholinesterase inhibitors and potential multitarget agents for Alzheimer's disease treatment
    Галина Ф. Махаева, Sofya V. Lushchekina, Надежда Владимировна Ковалева, T. Yu. Astakhova, Natalia P. Boltneva, Елена Владимировна Рудакова, Olga G. Serebryakova, Alexey N. Proshin, Igor V. Serkov, Т. П. Трофимова et al. · 2021 · Bioorganic Chemistry
85. Design, synthesis and evaluation of rivastigmine and curcumin hybrids as site-activated multitarget-directed ligands for Alzheimer’s disease therapy
    Yujie Li, Peng Peng, Li Tang, Yunzhen Hu, Yongzhou Hu, Rong Sheng · 2014 · Bioorganic & Medicinal Chemistry
86. Design, synthesis and biological evaluation of novel O-carbamoyl ferulamide derivatives as multi-target-directed ligands for the treatment of Alzheimer’s disease
    Zhipei Sang, Keren Wang, Ping Bai, Anguo Wu, Jian Shi, Wenmin Liu, Gaofeng Zhu, Yiling Wang, Yu Lan, Zude Chen et al. · 2020 · European Journal of Medicinal Chemistry
87. Probing the mid-gorge of cholinesterases with spacer-modified bivalent quinazolinimines leads to highly potent and selective butyrylcholinesterase inhibitors
    Xinyu Chen, Irina G. Tikhonova, Michael W. Decker · 2010 · Bioorganic & Medicinal Chemistry
88. Design, synthesis and evaluation of isaindigotone derivatives as dual inhibitors for acetylcholinesterase and amyloid beta aggregation
    Jinwu Yan, Yan‐Ping Li, Wen-Jie Ye, Shuo-Bin Chen, Jinqiang Hou, Jia‐Heng Tan, Tian‐Miao Ou, Ding Li, Lian‐Quan Gu, Zhi‐Shu Huang · 2012 · Bioorganic & Medicinal Chemistry
89. Iron-chelating backbone coupled with monoamine oxidase inhibitory moiety as novel pluripotential therapeutic agents for Alzheimer’s disease: a tribute to Moussa Youdim
    Orly Weinreb, Silvia A. Mandel, Orit Bar‐Am, Tamar Amit · 2011 · Journal of Neural Transmission
90. Novel multitarget-directed ligands targeting acetylcholinesterase and σ1 receptors as lead compounds for treatment of Alzheimer's disease: Synthesis, evaluation, and structural characterization of their complexes with acetylcholinesterase
    Julien Lalut, Gianluca Santoni, Delphine Karila, Cédric Lecoutey, Audrey Davis, Florian Nachon, Israel Silman, Joel L. Sussman, Martin Weik, Tangui Maurice et al. · 2018 · European Journal of Medicinal Chemistry
91. 4-(3-Nitrophenyl)thiazol-2-ylhydrazone derivatives as antioxidants and selective hMAO-B inhibitors: synthesis, biological activity and computational analysis
    Daniela Secci, Simone Carradori, Anél Petzer, Paolo Guglielmi, Melissa D’Ascenzio, Paola Chimenti, Donatella Bagetta, Stefano Alcaro, Gökhan Zengin, Jacobus Petrus Petzer et al. · 2019 · Journal of Enzyme Inhibition and Medicinal Chemistry
92. Supraphysiologic-dose anabolic–androgenic steroid use: A risk factor for dementia?
    Marc J. Kaufman, Gen Kanayama, James I. Hudson, Harrison Graham Pope · 2019 · Neuroscience & Biobehavioral Reviews
93. In silico screening of glycogen synthase kinase-3β targeted ligands against acetylcholinesterase and its probable relevance to Alzheimer’s disease
    Nasimudeen R. Jabir, Shazi Shakil, Shams S. M. Tabrez, Mohd Shahnawaz Khan, Md Tabish Rehman, Abdul Bakrudeen Ali Ahmed · 2020 · Journal of Biomolecular Structure and Dynamics
94. Soluble Sugar-Based Quinoline Derivatives as New Antioxidant Modulators of Metal-Induced Amyloid Aggregation
    Valentina Oliveri, Giuseppa Ida Grasso, Francesco Bellia, Francesco Attanasio, Maurizio Viale, Graziella Vecchio · 2015 · Inorganic Chemistry
95. NO-Donating Tacrine Hybrid Compounds Improve Scopolamine-Induced Cognition Impairment and Show Less Hepatotoxicity
    Lei Fang, Dorothea Appenroth, Michael W. Decker, Michael Kiehntopf, Amelie Lupp, Sixun Peng, Christian Fleck, Yihua Zhang, Jochen Lehmann · 2008 · Journal of Medicinal Chemistry
96. Multifunctional iron-chelators with protective roles against neurodegenerative diseases
    A.C.C. Nunes, Sérgio M. Marques, Catarina Quintanova, Diana Filipa Silva, Sandra M. Cardoso, Sı́lvia Chaves, Maria Amélia Santos · 2013 · Dalton Transactions
97. Tricyclic phenothiazine and phenoselenazine derivatives as potential multi-targeting agents to treat Alzheimer's disease
    Gary Tin, Tarek Mohamed, Nyasha Gondora, Michael A. Beazely, Praveen P. N. Rao · 2015 · MedChemComm
98. Dimebon enhances hippocampus-dependent learning in both appetitive and inhibitory memory tasks in mice
    Julie Vignisse, Harry W.M. Steinbusch, Alexei Bolkunov, João Pedro Costa-Nunes, Ana Isabel Santos, Christian Grandfils, Сергей Олегович Бачурин, Tatyana V. Strekalova · 2010 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
99. Novel Tacrine-Scutellarin Hybrids as Multipotent Anti-Alzheimer’s Agents: Design, Synthesis and Biological Evaluation
    Katarína Špilovská, Jan Korábečný, Vendula Šepsová, Daniel Jun, Martina Hrabinová, Petr Jošt, Ľubica Múčková, Ondřej Soukup, Jana Janočková, Tomas Kucera et al. · 2017 · Molecules
100. Synthesis and evaluation of isoprenylation-resveratrol dimer derivatives against Alzheimer's disease
     Yan-Wei Tang, Cunjian Shi, Huali Yang, Pei Cai, Qiaohong Liu, Xuelian Yang, Ling‐Yi Kong, Xiaobing Wang · 2018 · European Journal of Medicinal Chemistry